Pharming Group (OTCMKTS:PHGUF) Shares Gap Up – What’s Next?

Pharming Group NV (OTCMKTS:PHGUF)’s stock price gapped up before the market opened on Wednesday . The stock had previously closed at $1.20, but opened at $1.25. Pharming Group shares last traded at $1.25, with a volume of 200 shares changing hands.

Pharming Group Trading Down 4.2%

The stock’s fifty day moving average price is $1.46 and its 200 day moving average price is $1.61. The stock has a market cap of $771.73 million, a PE ratio of 57.53 and a beta of 0.45. The company has a quick ratio of 2.06, a current ratio of 2.63 and a debt-to-equity ratio of 0.40.

Pharming Group (OTCMKTS:PHGUF) last issued its earnings results on Thursday, May 7th. The biotechnology company reported ($0.01) earnings per share for the quarter. Pharming Group had a return on equity of 4.64% and a net margin of 3.30%.The business had revenue of $72.45 million during the quarter, compared to analysts’ expectations of $92.06 million.

About Pharming Group

Pharming Group NV is a Netherlands-based biopharmaceutical company specializing in the development and commercialization of protein replacement therapies for rare diseases. Founded in 1988 and headquartered in Leiden, the company leverages transgenic technology to produce recombinant proteins, with its flagship product RUCONEST (recombinant C1 esterase inhibitor) indicated for the treatment of acute hereditary angioedema (HAE) attacks. RUCONEST is approved and marketed in the United States, Europe and several other territories through partnerships with leading specialty pharmaceutical companies.

Beyond RUCONEST, Pharming maintains a diversified pipeline targeting unmet needs in rare and ultra-rare disorders.